The PennZone

  • Home
  • Non-profit
  • Health
  • Books
  • Marketing
  • Business
  • Entertainment
  • Sports
  • Legal

OnPacePlus Announces the Release of CoviSecure
The PennZone/10148683

Trending...
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
  • Hunter's Garage Teams Up With The Small Batch for a Free Thanksgiving Meal
  • RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase
Product helps public and private entities
manage disease status enabling a safe return to work/school

WEST CHESTER, Pa. - PennZone -- Faced with an evolving pandemic and continued vaccine hesitancy, workplaces, schools, and other organizations are searching for solutions to help them manage their risk and get back to normal. OnPacePlus, a leading provider of solutions for empowering patients and medical providers announces the availability of our CoviSecure risk management product. CoviSecure provides tracking of exposure, symptoms, vaccine status, contact tracing and quarantine status for any organization needing help managing risk for their workforce, students or other population. In partnership with Mathematica, CoviSecure leverages Mathematica's 19&Me algorithm providing an individual their personalized risk score for COVID-19. Using CoviSecure individuals and communities can assess their safety in their return to the workplace or school.

CoviSecure is delivered as a series of quick and easy interviews on a mobile phone, tablet, or computer browser. The interviews can be completed in less than a minute, providing real-time status information to individuals and the organization. The data can be leveraged to navigate a safe return or to manage overall risk factors requiring further action.

More on The PennZone
  • Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®
  • The Villari Firm, PLLC Named to the 2027 Edition of Best Law Firms
  • Pittsburgh Family Law Firm Pollock Begg Celebrates 16th Consecutive Best Law Firms Ranking
  • Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
  • A Powerful Encounter Awaits Philadelphia: Dr. Mattie Nottage Joins Brother Marcus on Air

Dr. Christopher Williams, founder and CEO of OnPacePlus commented, "In developing CoviSecure, we sought input from a variety of doctors, corporate risk managers, and educational institutions to craft a product that would help mitigate the pandemic's effects on both public and private institutions. We developed product features to allow ease of use and the efficient capture of critical information empowering real-time decisions on workforce management. Using CoviSecure, organizations can manage risk efficiently and make informed decisions that help save time, precious resources, and ultimately lives."

CoviSecure provides an individual's personalized risk score following each interview, based on an advanced algorithm created by Mathematica, a premiere research and digital services organization with expertise at the intersection of data, methods, policy, and practice headquartered in Princeton, NJ and with offices throughout the U.S. and abroad.

The product is now widely available, affordably priced, and ready for implementation within your organization.

For more information, please contact OnPacePlus at (800) 428-4844 or by email at getcovisecure@onpaceplus.com.

Contact
Dave Davis
***@onpaceplus.com


Source: OnPacePlus
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • AI Trading Agents Analyze Pharmaceutical Stocks as Biotech Innovation Draws Attention (LLY, GILD, BSX, AZN, ABBV, MRNA)
  • Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
  • Freight Broker 911 and Milton Collier Introduce "What's The 911?"—A New Podcast Built on Real Talk, Real Freight, and Real Opportunity
  • PropAccount.com Launches PropWallet, Turning Prop Firm Payouts Into Repeat Sales
  • Hope Survives Announces Hidden Impact, Its Second Brain Injury Podcast
  • Household Staffing Recognized as Principal Benefactor of the Nanny Relief Fund
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • TrueNorth Wellness Services Expands Rural Behavioral Health Care in Fulton County with Technology
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
  • Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
  • Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
  • Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England

Popular on PennZone

  • ASSIST Software Wins Volkswagen Challenge for Automated Quality Inspection - 119
  • New Children's Picture Book "Tippy Tay" Explores the Dangers of Peer Pressure and the Importance of - 110
  • New Children's Picture Book "Adam's Apple" Celebrates Childhood Curiosity and the Funny Misundersta - 109
  • What Mold Remediation Costs in Gettysburg, PA: 2026 Price Ranges by Job Type
  • LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
  • Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources
  • Pittsburgh Digital Marketing Agency Moves to Babcock Boulevard in the North Hills
  • Corner Property Management AAMC Expands Presence with Clover Mill Management Agreement
  • Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon
  • Sycamore Dove Releases "Loving Every Moment"

Similar on PennZone

  • New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
  • OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Ten Ten Ten Announces Maximizing Quality Performance, a Value-Based Care Implementation Guide
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Best Black Friday 2026 Deals on Lightweight Foldable Electric Wheelchairs – Save Up to 60%
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us